Omnilax (Macrogol 4000)

Omnilax (macrogol 4000) is used as an osmotic laxative to manage conditions affecting bowel transit.

• Chronic constipation: softens stool and promotes regular bowel movements in patients with persistent constipation.
• Occasional constipation: provides rapid relief of infrequent constipation episodes.
• Bowel preparation: facilitates intestinal cleansing before colonoscopy or other diagnostic procedures.

• Macrogol 4000 is a high‑molecular‑weight polyethylene glycol that is poorly absorbed from the gastrointestinal tract. It creates an osmotic gradient that draws water into the lumen, increasing stool water content and volume. The resulting soft, bulky stool stimulates peristalsis, enhancing transit and promoting evacuation without significant electrolyte shifts. The polymer remains in the intestinal lumen throughout its passage, providing a sustained laxative effect.

Macrogol 4000 may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Abdominal bloating: feeling of fullness or swelling in the abdomen.
• Flatulence: increased intestinal gas.
• Nausea: mild sensation of wanting to vomit.
• Diarrhea: loose, watery stools.
• Abdominal cramps: intermittent stomach pain.
• Headache: mild to moderate head discomfort.

Serious or Rare Side Effects

• Severe electrolyte imbalance: abnormal levels of sodium, potassium or other electrolytes.
• Allergic reaction: rash, itching, swelling or difficulty breathing.
• Severe abdominal pain: intense or persistent pain requiring medical attention.
• Rectal bleeding: presence of blood in stool.
• Dehydration: excessive fluid loss leading to dizziness or low blood pressure.

Before using Omnilax, certain precautions should be considered to ensure safe and effective use.

• Hydration status: assess and maintain adequate fluid intake during treatment.
• Intestinal obstruction: avoid use in patients with known or suspected bowel blockage.
• Renal impairment: use cautiously and monitor renal function in patients with kidney disease.
• Electrolyte monitoring: consider periodic electrolyte checks during prolonged therapy.
• Concomitant laxatives: limit use of other osmotic or stimulant laxatives to reduce risk of imbalance.
• Store at room temperature: keep in the original container, protect from moisture and heat.

Macrogol 4000 can affect the absorption of several concomitant medications.

Major Interactions (Avoid)

• Other osmotic laxatives: combined use may cause excessive fluid loss and electrolyte disturbances.
• High‑dose mineral supplements: may reduce effectiveness of macrogol and alter mineral balance.

Moderate Interactions (Monitor Closely)

• Antacids: may have reduced absorption when taken together.
• Oral contraceptives: macrogol may decrease plasma levels, consider alternative contraception.
• Digoxin: possible reduced absorption, monitor therapeutic levels.
• Lithium: decreased lithium levels, monitor serum concentrations.
• Warfarin: potential alteration of INR, monitor coagulation status.